We are live on ! Find out more
SIM

Stelliam Investment Management Portfolio holdings

AUM $404M
1-Year Est. Return 5.1%
This Fund
S&P 500
This Quarter Est. Return
+16.12%
1 Year Est. Return
-5.1%
3 Year Est. Return
+21.26%
5 Year Est. Return
+17.69%
10 Year Est. Return
AUM
$2.45B
AUM Growth
+$353M
Cap. Flow
+$82.4M
Cap. Flow %
3.36%
Top 10 Hldgs %
33.08%
Holding
60
New
8
Increased
29
Reduced
13
Closed
10

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$45.5M
2
C icon
Citigroup
C
+$41.6M
3
MON
Monsanto Co
MON
+$38.2M
4
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
+$35.4M
5
CHE icon
Chemed
CHE
+$28.2M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$69.4M
2
COF icon
Capital One
COF
+$48.1M
3
SNDK
SANDISK CORP
SNDK
+$26.3M
4
LPX icon
Louisiana-Pacific
LPX
+$24.3M
5
STX icon
Seagate
STX
+$19.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.46%
2 Technology 17.35%
3 Industrials 13.76%
4 Energy 12.86%
5 Financials 11.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COF icon
51
Capital One
COF
$135B
-700,000
Closed -$48.1M
HOV icon
52
Hovnanian Enterprises
HOV
$792M
-46,600
Closed -$6.09M
JBLU icon
53
JetBlue
JBLU
$2.2B
-2,306,500
Closed -$15.4M
LPX icon
54
Louisiana-Pacific
LPX
$5.34B
-1,380,000
Closed -$24.3M
MPC icon
55
CALL
Marathon Petroleum
MPC
$92.1B
-473,000
Closed -$15.2M
SPY icon
56
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$811B
-312,500
Closed -$52.5M
TEVA icon
57
Teva Pharmaceuticals
TEVA
$42.9B
-1,837,500
Closed -$69.4M
TTWO icon
58
Take-Two Interactive
TTWO
$47.5B
-850,000
Closed -$15.4M
VECO icon
59
CALL
Veeco
VECO
$3.09B
-236,500
Closed -$8.8M
BBG
60
PUT
DELISTED
Bill Barrett Corp
BBG
-250,000
Closed -$6.28M

Similar funds

Stelliam Investment Management's Q4 2013 Portfolio in Review

As of Q4 2013, Stelliam Investment Management held 60 positions worth $2.45B, up 17% from $2.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Stelliam Investment Management deployed $82.4M of net new capital in Q4 2013, opening 8 new positions and adding to 29 existing holdings. Its largest new stake was Amgen: 400,000 shares worth $45.7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was SANDISK CORP, an estimated $26.3M trimmed.

  • Stelliam Investment Management's largest Q4 2013 buy was Amgen: 400,000 shares worth $45.7M.
  • Stelliam Investment Management added most to GameStop in Q4 2013, an estimated $19.7M increase.
  • Stelliam Investment Management's biggest Q4 2013 reduction was SANDISK CORP, cutting an estimated $26.3M.
  • Stelliam Investment Management fully exited Teva Pharmaceuticals in Q4 2013, selling an estimated $69.4M.
  • Stelliam Investment Management's ten largest holdings make up 33% of its $2.45B portfolio in Q4 2013.
  • Stelliam Investment Management opened 8 new positions and closed 10 in Q4 2013.
  • Stelliam Investment Management's portfolio value rose 17% quarter-over-quarter to $2.45B.

Based on Stelliam Investment Management's 13F filing for Q4 2013, filed 14 Feb 2014.